SITC Leaders Publish Special Report on Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes
SITC leaders played a key role in developing a White Paper on Adoptive Cell Therapy for Cancer with Tumor-Infiltrating Lymphocytes: A Report of the CTEP Subcommittee on Adoptive Cell Therapy. On behalf of the Immunotherapy Task Force of the NCI Investigational Drug Steering Committee, Jeffrey Weber, Michael Atkins, Patrick Hwu, Laszlo Radvanyi, Mario Sznol and Cassian Yee prepared the report, which appeared in the April 2011 issue of Clinical Cancer Research. A summary of the report is available on the SITC website.
Update on the Cancer Immunotherapy Trials Network (CITN)
The NCI has selected 27 member sites in US and Canada to participate in the CITN. Many are SITC members. In May CITN Member Site PIs will meet at the NIH to finalize selection criteria for proposals for immunotherapy trials to be conducted with the CITN and to discuss ideas and form concept working groups to propose and review CITN concepts. Read More…
Join us November 1-6, 2011 in North Bethesda, MD for our 26th Annual Meeting and Associated Programs for scientific exchange of the most cutting-edge preclinical and clinical data on immunotherapies and biological therapy of cancer!
Abstract Submission Opens: May 2, 2011
Early Registration Opens: May 2, 2011
Free SITC Webinars Available
|
 |
|
 |
The Primer webinar was supported by educational grants from Dendreon Corporation and Prometheus Laboratories, Inc. and programmed by SITC.
Register today for “Cancer Immunology and Immunotherapy: Building on Success”
Date: September 22-23, 2011
Location: National Institutes of Health, Bethesda, MD
The Center for Cancer Research at the National Cancer Institute is hosting a 2-day national symposium entitled “Cancer Immunology and Immunotherapy: Building on Success.” This NCI-sponsored conference, organized by Steven Rosenberg, will host leaders in the field of cancer immunology and immunotherapy. The program this year includes recent advances in both translational and clinical research, and should be an exciting forum for discussion and debate on immunologic approaches to prevent and treat cancer. Read More…
Renew Your 2011 Membership Dues Today
Simply click on the green "Pay Dues Online" button, log into your account and click on "Renew My Dues" in the Members Only section.
Call for Papers
The Journal of Immunotherapy, the official journal of the Society for Immunotherapy of Cancer, has issued a call for papers. With an impact factor of 3.203, JOI is a leading journal in the fields of immunology and oncology. Visit the journal website at www.immunotherapy-journal.com. For manuscript submission, go to: www.editorialmanager.com/jit/.
Mark your calendar for the SITC 27th Annual Meeting & Associated Programs
October 25-28, 2012
North Bethesda, MD
This is an event you do not want to miss!
